Closed
Curated literature based database of germline human genomic variants database
NHS England
- Value
- £2,817,319.20
- Published
- 5 Oct 2026
- Deadline
- 23 Oct 2026
- Procedure
- Not stated
- Category
- 72320000 — Database services
- Location
- London, UKI45, SE1 8UG, United Kingdom
- Notice reference
- 093928-2026
Requirements summary
NHS England is running a planning-stage market engagement (RFI) for a curated, literature-based database or tool of germline human genomic variants. It would let clinicians search rare inherited disease mutations, review known mutations for a disease, interpret test results, identify likely causal variants, and integrate variant data into NGS pipelines, with variants searchable by transcript. The lot is valued at GBP 2,817,319.20 gross (GBP 2,347,766 net), with a contract period from 2028-01-01 to 2030-03-30, and suppliers are invited to respond by 2026-10-23.
Key requirements
- Curated database or tool that collates all published germline human genomic variants into a detailed repository
- Clinician search for rare inherited disease mutations and overviews of known mutations for a given disease
- Support for interpreting clinical test results and identifying likely causal mutations in variant lists
- Variants searchable by transcript to reduce scientific analysis time and patient turnaround times
- Integration of mutation content into custom NGS pipelines or data repositories
- Lot valued at GBP 2,817,319.20 gross (GBP 2,347,766 net), contract period 2028-01-01 to 2030-03-30, open to SME and VCSE suppliers
- Respond to the RFI questionnaire by 2026-10-23; notice is planning-stage with no guarantee of future procurement
Similar open notices
- Market Intelligence and Document Search PlatformTHE FINANCIAL REPORTING COUNCIL LIMITED
- ID 6575748 - DFE – OITFET - Provision, Implementation, and Support of a Case Management System, Customer Portal and Integration with a Public RegisterDepartment for the Economy
- Project Integrator Services FrameworkHS1 Ltd (t/a London St. Pancras Highspeed)
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England
- NHS regional & local insightNHS England